These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 25244545)

  • 1. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor retention in care one-year after viral suppression: a significant predictor of viral rebound.
    Crawford TN
    AIDS Care; 2014; 26(11):1393-9. PubMed ID: 24848440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus.
    Torian LV; Wiewel EW; Liu KL; Sackoff JE; Frieden TR
    Arch Intern Med; 2008 Jun; 168(11):1181-7. PubMed ID: 18541826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
    Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
    JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study.
    Tripathi A; Youmans E; Gibson JJ; Duffus WA
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):751-8. PubMed ID: 21142607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare facility characteristics associated with achievement and maintenance of HIV viral suppression among persons newly diagnosed with HIV in New York City.
    Wiewel EW; Borrell LN; Jones HE; Maroko AR; Torian LV
    AIDS Care; 2019 Dec; 31(12):1484-1493. PubMed ID: 30909714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
    Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Holloway J; Johnson M; Phillips AN
    HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care?
    Torian LV; Wiewel EW
    AIDS Patient Care STDS; 2011 Feb; 25(2):79-88. PubMed ID: 21284498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City.
    Wiewel EW; Borrell LN; Jones HE; Maroko AR; Torian LV
    AIDS Behav; 2017 Dec; 21(12):3557-3566. PubMed ID: 28160107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study.
    Farmer A; Wang X; Ganesan A; Deiss RG; Agan BK; O'Bryan TA; Akers K; Okulicz JF
    AIDS Res Ther; 2016; 13():16. PubMed ID: 27006682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage to Care After HIV Diagnosis in New York City: Better Than We Thought.
    Xia Q; Zhong Y; Wiewel EW; Braunstein SL; Torian LV
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e18-e21. PubMed ID: 28398989
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in community viral load among HIV-infected persons in New York City.
    Laraque F; Mavronicolas HA; Robertson MM; Gortakowski HW; Terzian AS
    AIDS; 2013 Aug; 27(13):2129-39. PubMed ID: 24384591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital signs: HIV prevention through care and treatment--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1618-23. PubMed ID: 22129997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.